Posts
- 2025 Federal Budget Signals Change—But Toxicology Remains Vital
- ADLM Voter Voice
- Detecting Nitazenes: Protecting Patients Against a New Class of Ultra-Potent Synthetic Opioids
- FDA LDT Compliance & Quasar’s Phase I Implementation
- FDA LDT Phase 1 Implementation: A Practical Approach
- FDA LDT Resources
- FDA LDT Update: ACLA Challenges FDA Lab Test Rules
- FDA LDT Update: Chevron Ruling
- FDA LDT Update: Dr. Paul, Rep. Finstad Aim to Repeal FDA Lab Test Rule
- FDA LDT Update: Lawmakers Seek to Repeal FDA Lab Test Rule
- FDA LDT Update: Quasar Instruments
- Quasar’s Perspective on the FDA’s Phased LDT Framework
- Regulatory Shake-Up: FDA’s LDT Final Rule Faces Legal Battles & Industry Uncertainty
- Summary of FDA LDT Court Ruling and Implications
- Welcome To Our Blog!
- Will the Trump Administration Change the FDA’s LDT Rule?